Votre panier est vide
Commencez à ajouter des peptides de recherche à votre panier.
PARCOURIR LES PRODUITS
Research GradeBremelanotide · 1-2-Day Delivery to Leicester
A synthetic melanocortin receptor agonist studied for its effects on sexual function through central nervous system pathways. PT-141 is the only melanocortin-based compound FDA-approved (as Vyleesi) for hypoactive sexual desire disorder.
PT-141 (Bremelanotide) activates the melanocortin-4 receptor (MC4R) in the central nervous system, modulating sexual desire and arousal pathways. Unlike PDE5 inhibitors that act peripherally, PT-141 works through central nervous system mechanisms, representing a novel approach to sexual dysfunction research.
Peptides Pharma delivers PT-141 research vials directly to Leicester with 1-2-day tracked delivery. Order online at peptidespharma.com and receive your research-grade lyophilized vial at your door.
Peptides Pharma PT-141 is priced at €65 per vial, which contains a 30-day supply of 10mg in a pre-mixed, ready-to-use vial system. Free UK delivery on orders over €175.
Yes, PT-141 is legal to purchase for research purposes in Leicester and across the UK. Peptides Pharma products are sold strictly for research use only.
Peptides Pharma PT-141 exceeds 99% purity, verified by independent HPLC analysis. Each batch comes with a Certificate of Analysis from a third-party laboratory.
PDE5 inhibitors (sildenafil, tadalafil) work peripherally on blood vessels. PT-141 works centrally through MC4R in the brain, modulating desire and arousal pathways. It is the first centrally-acting compound approved for sexual dysfunction.
PT-141 was derived from Melanotan II by removing the melanogenic (skin darkening) activity while retaining MC4R selectivity for sexual function. PT-141 is more selective for MC4R, while MT-II is non-selective across melanocortin receptors.
1-2-day tracked delivery. Pre-mixed & ready to use. >99% purity guaranteed.
ORDER PT-141 — €65
